PULMATRIX, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
PULMATRIX, INC. (PULM) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $676.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-03-26
- 2019-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $676.00K.
- 2019-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $169.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $164.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $327.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2019-12-31 | $676.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $169.00K 10-Q · filed 2019-11-01 |
| 2018-09-30 | $164.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $327.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $491.00K 10-Q · filed 2018-05-11 |
| 2017-09-30 | $158.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $316.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $474.00K 10-Q · filed 2017-05-05 |
| 2016-09-30 | $153.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $305.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $458.00K 10-Q · filed 2016-05-05 |
| 2015-09-30 | $151.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |